Clinical Research Directory
Browse clinical research sites, groups, and studies.
Vagal Stimulation in POTS
Sponsor: Vanderbilt University Medical Center
Summary
The purpose of this study is to investigate how the electrical stimulation of a nerve in the skin of the earlobe (transcutaneous vagal nerve stimulation), alone or in combination with two medications (galantamine and pyridostigmine), affects the way the autonomic (involuntary) nervous system controls heart rhythm, symptoms on standing, and inflammatory markers in female patients with postural tachycardia syndrome (POTS). The study consists of 2 parts: a screening (1-2 study days), and 3 testing days. The study will take 5 days total and about 16 participants will be screened for the study. The investigators estimate 13 will be eligible to participate in all of the study days.
Official title: Vagal Stimulation in POTS - The Autonomic Inflammatory Reflex (Pilot 3)
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
11
Start Date
2017-09-30
Completion Date
2026-12
Last Updated
2025-08-05
Healthy Volunteers
No
Conditions
Interventions
placebo sugar pill
placebo single oral dose
Pyridostigmine Pill
pyridostigmine bromide 30 mg single oral dose
Galantamine Pill
Galantamine hydrobromide 8mg single oral dose
Vagal stimulation
Vagal stimulation will be given at 50 Hz during the tilt table tests
Sham vagal stimulation
Sham vagal stimulation will be given at 0.01 mA during the tilt table tests
Locations (1)
Autonomic Dysfunction Center/ Vanderbilt University Medical Center
Nashville, Tennessee, United States